Industry Focus

Healthcare: Are Biotech Stocks Really Overvalued?

Informações:

Sinopsis

Biotech stocks eye-popping run has investors nervous of a bubble. Healthcare Fool's Michael Douglass and Todd Campbell weigh in with their take on biotech valuation.